QA: NightHawk Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001476963_2023_NightHawk_Biosciences_Inc.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.006711082337583817, 'aggregate_val': 31960244, 'exp_sum': 32176181, 'exp_to_value': {'LiabilitiesCurrent': 18037323, 'LiabilitiesNoncurrent': 3112387, 'remainder_Liabilities': 11026471}}

Graph

Absolute values for 0001476963, NightHawk Biosciences Inc.

  xvar xval
0 AssetsCurrent 50,054,259
1 IntangibleAssetsNetIncludingGoodwill 11,971,334
2 PropertyPlantAndEquipmentNet 20,480,375
3 remainder_Assets 21,890,944
4 LiabilitiesCurrent 18,037,323
5 LiabilitiesNoncurrent 3,112,387
6 remainder_Liabilities 10,810,534
7 CostOfGoodsAndServicesSold 6,401,018
8 SellingGeneralAndAdministrativeExpense 21,130,879
9 ResearchAndDevelopmentExpense 23,461,400
10 remainder_Expenses -2,210,327
11 remainder_Revenues 6,383,169
12 remainder_NetIncome -1,462,396
13 remainder_ComprehensiveNetIncome 547,356
  yvar yval
0 Assets 104,396,912
1 Liabilities 31,960,244
2 Expenses 48,782,970
3 Revenues 6,383,169
4 StockholdersEquity 72,436,668
5 NetIncome -43,862,197
6 ComprehensiveNetIncome -43,588,519
7 BaseVar 96,766,524
8 EconomicCapitalRatio 1.19

Edgar->Model Mapping

Feature Distribution

Change over Time